Check-Cap Ltd. (CHEK): Price and Financial Metrics

Check-Cap Ltd. (CHEK): $2.26

0.14 (-5.83%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

CHEK Price/Volume Stats

Current price $2.26 52-week high $4.63
Prev. close $2.40 52-week low $1.27
Day low $2.21 Volume 48,100
Day high $2.41 Avg. volume 231,476
50-day MA $2.22 Dividend yield N/A
200-day MA $2.82 Market Cap 13.22M

CHEK Stock Price Chart Interactive Chart >


Check-Cap Ltd. (CHEK) Company Bio


Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening. The company was founded by Yoav Kimchy in April 2005 and is headquartered in Isfiya, Israel.


CHEK Latest News Stream


Event/Time News Detail
Loading, please wait...

CHEK Latest Social Stream


Loading social stream, please wait...

View Full CHEK Social Stream

Latest CHEK News From Around the Web

Below are the latest news stories about CHECK-CAP LTD that investors may wish to consider to help them evaluate CHEK as an investment opportunity.

SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD

Symetryx Corporation ("Symetryx"), a Canadian venture company, is pleased to announce that the shareholders of Check-Cap Ltd. (NASDAQ: CHEK) voted overwhelmingly to elect all the director nominees proposed by Symetryx at the Annual General Meeting held on December 18th 2023. The CHEK shareholders, amongst other matters, voted overwhelmingly not to approve the proposed merger with Keystone Dental.

Yahoo | December 22, 2023

Check-Cap Board of Directors Issues Letter to Shareholders

ISFIYA, Israel, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Check-Cap, Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK) today issued the following letter from its Board of Directors to its shareholders and to the investment community: Dear Check-Cap Shareholders, The Board of Directors wishes to inform shareholders and the broader investment community that on December 12, 2023, Check-Cap won a motion filed by Symetryx in Israeli court, with the Court rejecting all claims raised by Symetryx, including th

Yahoo | December 15, 2023

CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL

Further to its news release of November 28, 2023, Symetryx continues to urge its fellow Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) shareholders to VOTE AGAINST the Keystone Dental and FOR the Symetryx slate of highly qualified and independent director nominees. See Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting (newswire.ca)

Yahoo | December 13, 2023

CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES

Further to its news release of November 28, 2023, Symetryx continues to urge its fellow Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) shareholders to VOTE AGAINST the Keystone Dental and FOR the Symetryx slate of highly qualified and independent director nominees. See Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting (newswire.ca)

Yahoo | December 8, 2023

CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES

Today, Symetryx Corporation ("Symetryx") once again encourages our fellow shareholders of Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) to review the news release issued by Yoav Kimchy, PhD, the Founder and former Chief Technology Officer, and shareholder, of Check-Cap, who has stated in an open letter to his fellow shareholders that the value of the Intellectual Property of Check-Cap was, in essence, disregarded and assigned no monetary value when valuing the Keystone Dental transaction. See Chec

Yahoo | December 5, 2023

Read More 'CHEK' Stories Here

CHEK Price Returns

1-mo 19.58%
3-mo 6.10%
6-mo -31.93%
1-year 68.66%
3-year -92.31%
5-year -95.41%
YTD 8.65%
2023 -5.45%
2022 -83.70%
2021 46.67%
2020 -73.26%
2019 -20.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!